经济导报记者|杜海近日,恒瑞医药、艾力斯、海创药业等创新药企陆续有产品成功获批,创新药板块关注度持续提升,中国创新药产业正驶入全球深海航道。在烟台,有一家国家级专精特新“小巨人”企业,也在创新药赛道疾驰。6月11日,山东博安生物技术股份有限公司(博安生物,6955.HK)发布公告称,公司通过配售方式发行3840万股H股,配售价为每股10.42港元,预期配售事项所得款项净额约为3.96亿港元,当中约...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.